Tricard T, Lacreuse I, Louis V, Schneider A, Chaussy Y, Soler L, Moog R, Lang H, Jacqmin D, Becmeur F
Service de chirurgie urologique, Nouvel hôpital civil, hôpitaux universitaire de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg, France; Service d'oncohématologie pédiatrique, hôpitaux universitaire de Strasbourg, CHRU de Hautepierre, avenue Molière, 67000 Strasbourg, France.
Service de chirurgie infantile, hôpitaux universitaire de Strasbourg, CHRU de Hautepierre, avenue Molière, 67000 Strasbourg, France; Service d'oncohématologie pédiatrique, hôpitaux universitaire de Strasbourg, CHRU de Hautepierre, avenue Molière, 67000 Strasbourg, France.
Arch Pediatr. 2017 Jul;24(7):650-658. doi: 10.1016/j.arcped.2017.04.003. Epub 2017 May 31.
Wilms tumors (WTs) are the most frequent renal tumors in children. Radical nephrectomy (RN) remains the gold-standard surgical treatment for this type of cancer. Excellent results in overall survival (>90%) make it possible to consider nephronic preservation. The objective of this systematic review is to evaluate the relevance of nephron-sparing surgery (NSS) for the treatment of nonsyndromic unilateral Wilms tumor (UWT) in children.
Articles in English related to "unilateral Wilms tumor, unilateral nephroblastoma, partial nephrectomy, nephron-sparing surgery, renal function" identified in the Medline library were screened and data were extracted to perform a qualitative systematic review.
We identified 377 articles, 14 of which were integrated into the analysis. Data on 4288 children were included, 3994 (93.1%) underwent RN, whereas 294 (6.8%) underwent NSS. Stage I anatomopathology resulted in 55.1% RN and 79% NSS. Overall survival and event-free survival were similar: respectively 95.7% and 92.8% after RN and 96 and 90.5% after NSS. Positive margin status was higher after NSS (8.5% vs 0.5%), but tumor rupture and local tumor recurrences were similar. The rate of mild to moderate renal function was higher after RN (42% vs 10% after NSS).
NSS is regularly performed for WT in case of bilateral or syndromic tumors, but the literature considering UWT does not show consensus. The superiority of NSS for renal outcomes has now been fully evaluated, but the main problem of this surgery in case of UWT is to ensure oncologic outcomes as good as outcomes after RN. WTs are usually massive tumors for which partial nephrectomy is contraindicated, but studies showed that chemotherapy before surgery could reduce tumor volume and make NSS possible. This review shows that NSS results seem to be as good as RN results and that preoperative chemotherapy should be highlighted for its participation in the reduction of the positive margin status. Although radiotherapy is used with caution because of its side effects, some studies showed that it gave excellent results for oncologic salvage after local recurrence. Constant progress in medical imaging and detection systems has led to the emergence of a new type of assistance for surgeons such as image reconstruction and vessel or urinary tract system segmentation. Virtual simulation of the operation based on a real case should help evaluate the feasibility of complex procedures in the near future.
NSS for UWT seems to be a credible therapeutic alternative. New technologies such as 3D reconstruction should help surgeons define the best parameters to select ideal tumors for this surgery in the near future. For the moment, small tumors (<4cm), distant from the renal hilum (ideally on the upper pole) that respect at least 50% of the renal parenchyma (ideally superficial with exophytic development) seem to be the perfect indication for NSS.
肾母细胞瘤(WTs)是儿童中最常见的肾肿瘤。根治性肾切除术(RN)仍然是这类癌症的金标准手术治疗方法。总体生存率的优异结果(>90%)使得考虑保留肾单位成为可能。本系统评价的目的是评估保留肾单位手术(NSS)治疗儿童非综合征性单侧肾母细胞瘤(UWT)的相关性。
筛选Medline数据库中与“单侧肾母细胞瘤、单侧肾胚细胞瘤、部分肾切除术、保留肾单位手术、肾功能”相关的英文文章,并提取数据进行定性系统评价。
我们共识别出377篇文章,其中14篇纳入分析。纳入了4288例儿童的数据,3994例(93.1%)接受了RN,而294例(6.8%)接受了NSS。I期解剖病理学结果显示,RN占55.1%,NSS占79%。总体生存率和无事件生存率相似:RN术后分别为95.7%和92.8%,NSS术后分别为96%和90.5%。NSS术后切缘阳性状态更高(8.5%对0.5%),但肿瘤破裂和局部肿瘤复发情况相似。RN术后轻度至中度肾功能的发生率更高(42%对NSS术后的10%)。
对于双侧或综合征性肿瘤的WT,NSS经常被实施,但关于UWT的文献并未达成共识。NSS对肾脏结局的优越性现已得到充分评估,但在UWT情况下,该手术的主要问题是确保肿瘤学结局与RN术后的结局一样好。WT通常是巨大肿瘤,禁忌行部分肾切除术,但研究表明术前化疗可缩小肿瘤体积并使NSS成为可能。本综述表明,NSS的结果似乎与RN的结果一样好,术前化疗因其有助于降低切缘阳性状态而应得到重视。尽管由于放疗的副作用而谨慎使用,但一些研究表明,它对局部复发后的肿瘤挽救效果极佳。医学成像和检测系统的不断进步导致了新型外科辅助手段的出现,如图像重建以及血管或泌尿系统分割。基于实际病例的手术虚拟模拟应有助于在不久的将来评估复杂手术的可行性。
UWT的NSS似乎是一种可靠的治疗选择。3D重建等新技术应有助于外科医生在不久的将来确定最佳参数,以选择适合该手术的理想肿瘤。目前,小肿瘤(<4cm),远离肾门(理想情况下位于上极),至少保留50%的肾实质(理想情况下为浅表外生性生长)似乎是NSS的完美适应证。